- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07943169
Wear, Clinical Performance and Computerized Occlusal Evaluation of Hybrid Versus Lithium Disilicates Ceramic CAD/CAM Overlays in Endodontically Treated Molars: A 24-Month Comparative Randomized Clinical Trial
This randomized clinical trial aims to compare the clinical performance, wear behavior and relative occlusal force distribution of hybrid ceramic and lithium disilicate CAD/CAM overlays in endodontically treated molars over a 24-month follow up period using Modified USPHS criteria, Geomagic control software and digital occlusal analyzer respectively
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Farah Khaled El Hindawy, PhD candidate
- Telefoonnummer: +201008771378
- E-mail: farah-khaled@dentistry.cu.edu.eg
Studie Contact Back-up
- Naam: Aya Mohamed Adly, Lecturer
- Telefoonnummer: +201221528843
- E-mail: Aya.Mohamed@dentistry.cu.edu.eg
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Inclusion criteria of patients: Healthy patients, compliant, having good oral hygiene, willing to commit to the follow up periods, patients without parafunctional habits
- Inclusion criteria of teeth included: endodontically treated first or second molars, opposing teeth present, consistent root canal fillings, no apical lesion or mobility present, large access cavities with at least one missing wall
Exclusion Criteria:
- Exclusion criteria of patients: patients having systemic diseases, pregnant females, not willing to commit to the follow up periods, patients with poor oral hygiene, patients having parafunctional habits
- Exclusion criteria of teeth: endodontically treated anterior or premolar teeth, endodontically treated third molars ,inconsistent root canal filling, presence of periapical lesion or mobility, lack of opposing teeth, conservative access cavities
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Endodontically treated molars will be restored using lithium disilicate CAD/CAM overlays
Endodontically treated molars will receive lithium disilicate CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay. |
Endodontically treated molars will be prepared to receive lithium disilicate CAD/CAM overlays. Preparation includes cuspal reduction of the buccal and lingual walls 1.5 to 2 mm, removal of all undermined enamel and slight flaring of the cavity walls to 6-10-degree divergence. Following cavity preparation, immediate dentin sealing and cavity optimization followed by scanning and milling of the restoration. Cementation will then follow based on manufacturer instructions using resin cement. Surface treatment including etching of the fitting surface using 9.5% hydrofluoric acid for 20 seconds followed by cleaning for 60 seconds using 37% phosphoric acid gel followed by silane application. |
|
Experimenteel: Experimental: Endodontically treated molars will be restored using Hybrid Ceramics CAD/CAM overlays
Endodontically treated molars will receive Hybrid ceramics CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay. |
Endodontically treated molars will be prepared to receive hybrid ceramics overlays following the concept of morphology driven preparation. This includes cuspal reduction for the buccal and lingual walls, removal of all undermined enamel, slight flaring of the cavity walls to 6-10-degree divergence. After proper cavity preparation, immediate dentin sealing and cavity optimization will be done followed by scanning, milling and finally cementation of the overlay restoration. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Wear Assessment
Tijdsspanne: baseline, 12 and 24 months
|
The volumetric loss of the overlays will be measured by the software Geomagic Control Software |
baseline, 12 and 24 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Clinical performance (Marginal Adaptation)
Tijdsspanne: baseline, 6, 12, 18 and 24 months
|
Marginal adaptation will be measured by two assessors following Modified USPHS criteria |
baseline, 6, 12, 18 and 24 months
|
|
Relative Occlusal load distribution
Tijdsspanne: Immediately, 6 and 12 months
|
relative occlusal load distribution will be measured by digital occlusal analysis system OccluSense |
Immediately, 6 and 12 months
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- Cairo CONS 3-7-5
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
The dataset contains coded but potentially re-identifiable clinical and patient information. Per the study confidentiality plan, data access is restricted to the principal investigator and study supervisors only with records stored securely under password-protected, limited access systems. No plan for sharing individual participant data with external researchers is currently in place.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .